Shelby Jackson

Shelby Jackson serves as a procurement professional responsible for managing complex acquisitions within a federal health and laboratory services environment. While their official title and agency are not publicly specified, their contracting activity centers on the acquisition of medical equipment, diagnostic supplies, and laboratory instrumentation critical to public health infrastructure. They oversee the full lifecycle of solicitations—from market research and requirements definition to contract award and administration—ensuring alignment with federal acquisition regulations and mission-critical operational needs. Their work supports the procurement of high-precision diagnostic tools and medical supply chains essential to clinical and research settings. Shelby Jackson maintains a broad network of vendors, primarily engaging merchant wholesalers of medical and dental supplies, analytical instrument manufacturers, and in-vitro diagnostic substance producers. While no single contractor dominates their portfolio, their contracting patterns reflect consistent engagement with established suppliers in the life sciences sector, including both large-cap manufacturers and niche specialty firms. Their approach emphasizes competitive bidding and technical compliance, fostering relationships with vendors capable of meeting stringent regulatory and performance standards. A striking 96.8% of Shelby Jackson’s acquisitions are conducted without set-asides, indicating a preference for full and open competition. However, they maintain a modest but deliberate commitment to small business participation, with 3.2% of awards designated as Total Small Business Set-Asides under FAR 19.5. This reflects a balanced approach—prioritizing market efficiency while ensuring opportunities for qualified small businesses in the medical and laboratory supply sectors. Their procurement focus is heavily concentrated in NAICS 423450 (medical equipment wholesale), 334516 (analytical laboratory instrument manufacturing), and 325413 (in-vitro diagnostic substance manufacturing), demonstrating deep expertise in clinical diagnostics and laboratory infrastructure. They routinely procure precision instruments, reagents, and supply chains supporting hospital labs, public health testing, and research facilities, indicating specialized knowledge in biomedical procurement and regulatory compliance for medical devices and diagnostics.